A recent survey conducted by the Pew Research Center sheds light on Americans’ perceptions of weight-loss drugs, particularly focusing on medications like Ozempic and Wegovy and their potential impact on combating obesity in the United States.
The survey revealed that approximately three-quarters of Americans are familiar with drugs like Ozempic and Wegovy, which are classified as GLP-1 agonists aimed at managing blood sugar levels and suppressing appetite.
Among those familiar with these drugs, a significant portion, accounting for 53%, view them as viable options for individuals dealing with obesity or weight-related health conditions.
However, only a small fraction, comprising 12%, see them as suitable for those without such conditions. The majority, 62%, express skepticism about their usage by individuals without weight-related health issues.
These medications have sparked a significant demand, resulting in supply shortages and raising concerns about off-label usage.
Ozempic, approved by the FDA for diabetes treatment, and Wegovy, sanctioned for individuals with obesity or excess weight alongside a weight-related health condition, have been at the forefront of this surge in demand.
While some experts hail drugs like Ozempic as potential breakthroughs in addressing obesity, the public remains cautiously optimistic about their impact.
Only 16% of respondents familiar with these medications believe they will significantly contribute to reducing obesity in the U.S., with 35% expecting some impact and 33% foreseeing minimal to no effect.
According to the Centers for Disease Control and Prevention (CDC), approximately four in ten U.S. adults are affected by obesity, a condition associated with various health risks, including heart disease and type 2 diabetes, and substantial healthcare costs.
The survey also delved into Americans’ perceptions regarding weight and weight loss.
A majority, comprising 65% of respondents, believe that willpower alone is insufficient for most people attempting to lose weight and maintain it. Instead, factors such as diet, exercise habits, stress, anxiety, and genetics are considered significant influencers of weight.
While diet topped the list of factors impacting weight, followed closely by exercise habits, stress and anxiety were also deemed to have considerable influence.
Access to grocery stores and safe places for exercise, described as social determinants of health by public health experts, were acknowledged as influential factors.
Overall, the survey highlights the nuanced views of Americans regarding weight-loss drugs and their potential role in addressing obesity.
Despite acknowledging the efficacy of these medications for individuals with weight-related health conditions, there remains skepticism about their broader impact on obesity in the country.
Moreover, the survey underscores the multifaceted nature of weight management, emphasizing the importance of considering various factors beyond sheer willpower in tackling the issue of obesity.